Impact of GVHD on lymphoma progression: Nationwide study from Japanese Society for Transplantation and Cellular Therapy
British Journal of Haematology · 2023
DOI: 10.1111/bjh.19041 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2023. Verfasst von Mizuki Watanabe und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Kyoto University Hospital, Kyoto, Japan. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Lymphoma, Non-Hodgkin, Lymphoma. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Takeda Science Foundation.
Abstract (Originalsprache)
The graft‐versus‐lymphoma (GVL) effect and its association with acute and chronic GVHD (aGVHD, cGVHD) has not been comprehensively elucidated. We retrospectively analysed 2204 Japanese patients with non‐Hodgkin lymphomas (NHLs; indolent B‐NHLs, n = 689; aggressive B‐NHLs, n = 720; mature T/NK‐NHLs, n = 795) receiving a first allo‐HSCT in 2003–2017. Pre‐transplant lymphoma control showed complete response (CR) in 759 and non‐CR in 1445. We assessed the impact of aGVHD/cGVHD on lymphoma progression and other outcomes. Although aGVHD/cGVHD showed no statistical impact on lymphoma progression in the overall cohort, their impact was clear in certain groups: Grade I‐II aGVHD in CR patients (HR, 0.63; 95% CI, 0.43–0.91), especially in mature T/NK‐NHL (HR, 0.46; 95% CI, 0.26–0.83) and extensive cGVHD in patients with mature aggressive B‐NHLs (HR, 0.55; 95% CI, 0.31–0.97). In total, limited cGVHD was associated with superior survivals (progression‐free survival: HR, 0.71; 95% CI, 0.56–0.90), whereas severe GVHDs showed negative impacts on them. Our results support the presence of GVL effects differentially associated with GVHD in different lymphoma subtypes/controls. Meanwhile, it was also suggested that we should manage GVHDs within a limited activity, considering the negative impact of severe GVHDs. As pre‐transplant lymphoma control remains a strong factor influencing transplant outcomes, improving its management is an important issue to be addressed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Kyoto University Hospital, Kyoto, Japan.
- Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
- Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
- Department of Hematology, Hyogo College of Medicine Hospital, Tokyo, Japan.
- Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
- Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.
ORCID-Profile: Mizuki Watanabe, Junya Kanda, Ken-Ichi Matsuoka, Hideyuki Nakazawa, Yoshiko Atsuta, Eisei Kondo
Förderung
- Japan Society for the Promotion of Science
- Takeda Science Foundation
Zitieren
APA
Watanabe, M., Kanda, J., Fukuda, T., Uchida, N., Ikegame, K., Kataoka, K., Kobayashi, H., Ara, T., Ishikawa, J., Matsuoka, K. I., Sugio, Y., Nakazawa, H., Ikeda, T., Atsuta, Y., Kondo, E., Suzuki, R., & Japanese Society for Transplantation and Cellular Therapy, Adult Lymphoma Working Group (2023). Impact of GVHD on lymphoma progression: Nationwide study from Japanese Society for Transplantation and Cellular Therapy. British Journal of Haematology. https://doi.org/10.1111/bjh.19041
Vancouver
Watanabe M, Kanda J, Fukuda T, Uchida N, Ikegame K, Kataoka K, et al. Impact of GVHD on lymphoma progression: Nationwide study from Japanese Society for Transplantation and Cellular Therapy. British Journal of Haematology. 2023. doi:10.1111/bjh.19041
BibTeX
@article{Watanabe2023,
author = {Watanabe, Mizuki and Kanda, Junya and Fukuda, Takahiro and Uchida, Naoyuki and Ikegame, Kazuhiro and Kataoka, Keisuke and Kobayashi, Hikaru and Ara, Takahide and Ishikawa, Jun and Matsuoka, Ken-Ichi and Sugio, Yasuhiro and Nakazawa, Hideyuki and Ikeda, Takashi and Atsuta, Yoshiko and Kondo, Eisei and Suzuki, Ritsuro and Japanese Society for Transplantation and Cellular Therapy, Adult Lymphoma Working Group, Japanese Society for Transplantation and Cellular Therapy, Adult Lymphoma Working Group},
title = {Impact of GVHD on lymphoma progression: Nationwide study from Japanese Society for Transplantation and Cellular Therapy},
journal = {British Journal of Haematology},
year = {2023},
doi = {10.1111/bjh.19041}
}
EUVIMED